Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2400 | 2258 | 35.3 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
2272 | 2 | HEPARIN INDUCED THROMBOCYTOPENIA//ARGATROBAN//HIRUDIN | 4638 |
2400 | 1 | THROMBIN INHIBITOR//HIRUDIN//XIMELAGATRAN | 2258 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THROMBIN INHIBITOR | authKW | 893396 | 7% | 40% | 167 |
2 | HIRUDIN | authKW | 841113 | 8% | 36% | 173 |
3 | XIMELAGATRAN | authKW | 538597 | 3% | 57% | 70 |
4 | MELAGATRAN | authKW | 470100 | 2% | 63% | 55 |
5 | FACTOR XA INHIBITOR | authKW | 463730 | 5% | 29% | 117 |
6 | FACTOR XA | authKW | 356988 | 5% | 23% | 114 |
7 | RECOMBINANT HIRUDIN | authKW | 239097 | 2% | 45% | 39 |
8 | ANTICOAGULANTS | authKW | 205975 | 11% | 6% | 247 |
9 | DX 9065A | authKW | 203376 | 1% | 79% | 19 |
10 | THROMBIN | authKW | 147107 | 9% | 5% | 208 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 20382 | 28% | 0% | 640 |
2 | Hematology | 16419 | 26% | 0% | 594 |
3 | Peripheral Vascular Diseases | 12820 | 22% | 0% | 507 |
4 | Chemistry, Organic | 2529 | 16% | 0% | 369 |
5 | Pharmacology & Pharmacy | 1617 | 18% | 0% | 399 |
6 | Biochemistry & Molecular Biology | 646 | 18% | 0% | 408 |
7 | Cardiac & Cardiovascular System | 631 | 8% | 0% | 176 |
8 | Biophysics | 61 | 3% | 0% | 69 |
9 | Chemistry, Multidisciplinary | 55 | 7% | 0% | 147 |
10 | Biochemical Research Methods | 31 | 2% | 0% | 51 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED COMBINATORIAL CHEM | 81795 | 0% | 55% | 11 |
2 | ZENTRUM VASKULARE BIOL MED | 71156 | 0% | 53% | 10 |
3 | CARDIOVASC THER EUT SECT | 40564 | 0% | 100% | 3 |
4 | NEW LEADS GENERAT | 40564 | 0% | 100% | 3 |
5 | UNIT PHARMACOL HAEMOSTASEOL | 32444 | 0% | 40% | 6 |
6 | MOL DESIGN ERS | 28808 | 0% | 24% | 9 |
7 | BIOPHYS PHYSIOL CELL | 27043 | 0% | 100% | 2 |
8 | DRUG DEV SCI GRP | 27043 | 0% | 100% | 2 |
9 | PROT CHEM 3 | 27043 | 0% | 100% | 2 |
10 | STRUCT CHEM ENZYMOL | 27043 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 35928 | 11% | 1% | 259 |
2 | THROMBOSIS RESEARCH | 35873 | 7% | 2% | 165 |
3 | THROMBOSIS AND HAEMOSTASIS | 28419 | 6% | 1% | 145 |
4 | HAEMOSTASIS | 22084 | 2% | 4% | 45 |
5 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 17142 | 3% | 2% | 58 |
6 | BLOOD COAGULATION & FIBRINOLYSIS | 10227 | 2% | 2% | 50 |
7 | JOURNAL OF ENZYME INHIBITION | 9693 | 1% | 4% | 16 |
8 | JOURNAL OF MEDICINAL CHEMISTRY | 8634 | 5% | 1% | 118 |
9 | PHARMAZIE | 6136 | 3% | 1% | 64 |
10 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 4511 | 0% | 3% | 11 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THROMBIN INHIBITOR | 893396 | 7% | 40% | 167 | Search THROMBIN+INHIBITOR | Search THROMBIN+INHIBITOR |
2 | HIRUDIN | 841113 | 8% | 36% | 173 | Search HIRUDIN | Search HIRUDIN |
3 | XIMELAGATRAN | 538597 | 3% | 57% | 70 | Search XIMELAGATRAN | Search XIMELAGATRAN |
4 | MELAGATRAN | 470100 | 2% | 63% | 55 | Search MELAGATRAN | Search MELAGATRAN |
5 | FACTOR XA INHIBITOR | 463730 | 5% | 29% | 117 | Search FACTOR+XA+INHIBITOR | Search FACTOR+XA+INHIBITOR |
6 | FACTOR XA | 356988 | 5% | 23% | 114 | Search FACTOR+XA | Search FACTOR+XA |
7 | RECOMBINANT HIRUDIN | 239097 | 2% | 45% | 39 | Search RECOMBINANT+HIRUDIN | Search RECOMBINANT+HIRUDIN |
8 | ANTICOAGULANTS | 205975 | 11% | 6% | 247 | Search ANTICOAGULANTS | Search ANTICOAGULANTS |
9 | DX 9065A | 203376 | 1% | 79% | 19 | Search DX+9065A | Search DX+9065A |
10 | THROMBIN | 147107 | 9% | 5% | 208 | Search THROMBIN | Search THROMBIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HAUPTMANN, J , STURZEBECHER, J , (1999) SYNTHETIC INHIBITORS OF THROMBIN AND FACTOR XA: FROM BENCH TO BEDSIDE.THROMBOSIS RESEARCH. VOL. 93. ISSUE 5. P. 203 -241 | 189 | 77% | 108 |
2 | LEE, YK , PLAYER, MR , (2011) DEVELOPMENTS IN FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.MEDICINAL RESEARCH REVIEWS. VOL. 31. ISSUE 2. P. 202-283 | 129 | 63% | 15 |
3 | STEINMETZER, T , STURZEBECHER, J , (2004) PROGRESS IN THE DEVELOPMENT OF SYNTHETIC THROMBIN INHIBITORS AS NEW ORALLY ACTIVE ANTICOAGULANTS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 17. P. 2297-2321 | 123 | 77% | 54 |
4 | SCHWIENHORST, A , (2006) DIRECT THROMBIN INHIBITORS - A SURVEY OF RECENT DEVELOPMENTS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 63. ISSUE 23. P. 2773-2791 | 107 | 62% | 59 |
5 | GUO, LW , MA, ST , (2015) ADVANCES IN INHIBITORS OF FXA.CURRENT DRUG TARGETS. VOL. 16. ISSUE 11. P. 1207 -1232 | 77 | 76% | 0 |
6 | PINTO, DJP , SMALLHEER, JM , CHENEY, DL , KNABB, RM , WEXLER, RR , (2010) FACTOR XA INHIBITORS: NEXT-GENERATION ANTITHROMBOTIC AGENTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 53. ISSUE 17. P. 6243 -6274 | 103 | 53% | 51 |
7 | CORRAL-RODRIGUEZ, MA , MACEDO-RIBEIRO, S , PEREIRA, PJB , FUENTES-PRIOR, P , (2010) LEECH-DERIVED THROMBIN INHIBITORS: FROM STRUCTURES TO MECHANISMS TO CLINICAL APPLICATIONS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 53. ISSUE 10. P. 3847-3861 | 89 | 66% | 20 |
8 | MARKWARDT, F , (1994) THE DEVELOPMENT OF HIRUDIN AS AN ANTITHROMBOTIC DRUG.THROMBOSIS RESEARCH. VOL. 74. ISSUE 1. P. 1-23 | 83 | 94% | 192 |
9 | CASIMIRO-GARCIA, A , DUDLEY, DA , HEEMSTRA, RJ , FILIPSKI, KJ , BIGGE, CF , EDMUNDS, JJ , (2006) PROGRESS IN THE DISCOVERY OF FACTOR XA INHIBITORS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 16. ISSUE 2. P. 119-145 | 63 | 94% | 27 |
10 | STEINMETZER, T , HAUPTMANN, J , STURZEBECHER, J , (2001) ADVANCES IN THE DEVELOPMENT OF THROMBIN INHIBITORS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 10. ISSUE 5. P. 845 -864 | 78 | 83% | 57 |
Classes with closest relation at Level 1 |